우리나라에서의 천식 및 만성폐쇄성폐질환 치료제 처방 양상
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 장진경 | - |
dc.contributor.author | 신현택 | - |
dc.contributor.author | 김해숙 | - |
dc.contributor.author | 손현순 | - |
dc.contributor.author | 박찬미 | - |
dc.contributor.author | 김주상 | - |
dc.contributor.author | 정복현 | - |
dc.contributor.author | 지은희 | - |
dc.contributor.author | 조정환 | - |
dc.date.available | 2020-02-28T21:44:35Z | - |
dc.date.created | 2020-02-12 | - |
dc.date.issued | 2014 | - |
dc.identifier.issn | 1226-6051 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/13947 | - |
dc.description.abstract | Purpose: The aim of this study was to investigate drug prescription patterns for the treatment of asthma and chronicobstructive pulmonary disease (COPD) patients in Korea. Methods: Ambulatory adult patients who were diagnosed andreceived treatment for the asthma (ICD-10 code J45) or COPD (ICD-10 code J44) from January 2009 to September2011 in two independent secondary hospitals in Korea were enrolled in this study. Prescribed drug lists were generatedbased on the evidence-based guidelines and prescribed drug dosage forms were identified from the patient medicalrecords and computerized drug prescription databases of the study centers. Results: Total numbers of asthma andCOPD patient enrolled in this study were 2,432 and 2,615, respectively. Individual prescription-based accumulated numbersof patient were 12,021 for asthma and 16,584 for COPD. The most commonly prescribed three drugs were oralpredisolone, oral formoterol and oral montelukast for asthma and oral formoterol, oral doxofylline and inhaled tiotropiumfor COPD. Frequencies of oral drugs were 83.4% and 63.3% while inhalers were 16.4% and 30.2%, for asthmaand COPD, respectively. Conclusion: The oral treatment was prescribed more in asthma and COPD patients than inhalers. To enhance the compliance of evidence-based guidelines for these chronic airway diseases, more realistic and specificstrategies to increase the use of inhalers recommended as primary treatment options for asthma and COPD wouldbe required. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | 한국임상약학회 | - |
dc.relation.isPartOf | 한국임상약학회지 | - |
dc.title | 우리나라에서의 천식 및 만성폐쇄성폐질환 치료제 처방 양상 | - |
dc.title.alternative | Drug Prescribing Patterns for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease in Korea | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 2 | - |
dc.identifier.bibliographicCitation | 한국임상약학회지, v.24, no.1, pp.26 - 32 | - |
dc.identifier.kciid | ART001864812 | - |
dc.citation.endPage | 32 | - |
dc.citation.startPage | 26 | - |
dc.citation.title | 한국임상약학회지 | - |
dc.citation.volume | 24 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | 지은희 | - |
dc.subject.keywordAuthor | asthma | - |
dc.subject.keywordAuthor | chronic obstructive pulmonary disease | - |
dc.subject.keywordAuthor | evidence-based guidelines | - |
dc.subject.keywordAuthor | inhalers | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.